Alkemy Bx
iten

Investor Relations

This section is maintained for archival purposes. As of July 14, 2025, the Company is no longer listed on the STAR segment of Borsa Italiana.

Alkemy S.p.A. is a leading company in the digital transformation segment in Italy. Alkemy enables the evolution of enterprises’ business defining the relevant strategy through the use of technology, data and creativity. The aim is to improve the operations and services supplied by large and medium enterprises, stimulating the evolution of their business model hand-in-hand with technological innovation and consumer conduct. Alkemy develops innovative projects throughout the chains of the various segments, such as, for example, telecommunications, media, consumer services, financial services and utilities, combining advanced technologies with innovative design, big data and creative communication. Alkemy integrates different competences, intervening as a single player in the Customer’s processes and operations, supplying multiple services that can impact the whole of the value chain. Indeed, Alkemy manages extensive projects aimed at transforming and evolving its customers’ business, assisting them from the definition of the strategy to be pursued through to the relevant implementation and subsequent management.

Alkemy Investor Relations department issues exhaustive disclosure to the financial community for a complete evaluation of the company’s results and prospects.

Our financial communication relies on the principles of continuity, clarity and transparency, as the bedrock to develop constructive dialogue with investors.

OPAAdmission Document AIMInformative prospect AIMFinancial Reportscorporate transactionsPress ReleasesDiffusion and storage of Regulated InformationPrice Sensitive Press ReleasesNon price sensitive press releasesCompany PresentationIR Contacts

TENDER OFFER CONCERNING ALKEMY S.P.A.

BEFORE ACCESSING THE INFORMATION AND DOCUMENTS CONTAINED IN THIS SECTION OF THIS WEBSITE, PLEASE READ AND ACCEPT THE DISCLOSURE BELOW.
With reference to the voluntary total voluntary tender offer (the “Offer”) concerning a total of 5,685,460 shares of Alkemy S.p.A. (the “Issuer”), representing 100% of the Issuer's share capital, promoted by Retex S.p.A. - Benefit Company (the “Offeror”) and announced on June 3, 2024 by means of a notice published pursuant to Article 102, paragraph 1, of Legislative Decree No. 58 of February 24, 1998, please note the following.
The Offer will be promoted exclusively in Italy, as the Issuer's shares are listed exclusively on “EuronextMilan,” an Italian regulated market organized and managed by Borsa Italiana S.p.A., and is subject to the disclosure requirements and procedural requirements under Italian law. In particular, the Offer will be made by means of the publication of an offer document subject to the approval of the Commissione Nazionale per le Società e la Borsa (the “Offer Document”). The Offer Document will contain the full description of the terms and conditions of the Offer, including the terms and conditions of acceptance. Prior to tendering in the Offer, shareholders of the Issuer are advised to carefully read the documentation concerning the Offer published in accordance with the law.
The Offer is not, and will not be, promoted or disseminated in the United States of America, Canada, Japan and Australia, or in any other country where such Offer is not permitted in the absence of authorization by the competent authorities or other compliance by the Offeror (such countries, including the United States of America, Canada, Japan and Australia, collectively, the “Other Countries”), nor by using domestic or international means of communication or commerce of the Other Countries (including, without limitation, the postal network, fax, electronic mail ,telephone and internet), nor through any facility of any of the financial intermediaries of the Other Countries, nor in any other manner.
Tendering in the Offer by persons residing in countries other than Italy may be subject to specific obligations or restrictions provided for by legal or regulatory provisions. It is the sole responsibility of persons intending to tender in the Offer to comply with such regulations and, therefore, prior to tendering in the Offer, such persons will be required to verify the existence and applicability of such regulations by contacting their advisors and complying with such regulations prior to tendering in the Offer. No copies of the Offer Document, or portions thereof, as well as copies of any documents relating to the Offer shall be, nor may be, sent, transmitted or distributed, directly or indirectly, - by any means whatsoever - in any or from any Other Country where the provisions of local law may give rise to civil, criminal or regulatory risks where information concerning the Offer is transmitted or made available to shareholders of the Issuer in such Other Country or in any other country where such conduct would constitute a violation of the laws of such country. Any person receiving such documents (including as custodian, fiduciary or trustee) is required not to send, transmit or distribute - in any manner whatsoever - the same to, or from, Other Countries. This section of this website, and the documents and/or information contained herein, do not constitute, nor may they be construed as, an offer, invitation or solicitation to buy or otherwise acquire, subscribe for, sell or otherwise dispose of financial instruments of the Issuer in the Other Countries. Anyone who intends to access this section of the Issuer's website and view the Offer Document and other documents published therein must read carefully and be fully aware of the above.
By selecting the “I ACCEPT” button, you represent and warrant - under your full responsibility - that you are not a U.S. Person, that you are not physically located and do not reside in the Other Countries, and that you have read, fully understand and accept and agree to abide by all of the above limitations.

TERMS AND CONDITIONS

To be able to access this section of the website you must read and accept the information given below, that the reader must carefully assess before reading, accessing, or using the information provided below in any other way. By accessing this section of the website, you agree to be subject to the terms and conditions hereafter, which may be modified or updated (and, for this reason, must be read completely every time that you access it).

The admission document posted on this section of the website (“Admission Document”) was drawn up in compliance with the issuer regulations of AIM Italia / Mercato Alternativo del Capitale (“AIM Issuer Regulations”) for the purposes of admission of the ordinary shares (the “Financial Instruments”) of Alkemy S.p.A. (the “Company”) on this multilateral system of negotiation organized and managed by Borsa Italiana S.p.A.

The offering of financial instruments contemplated in the Admission Document and any other information on these pages shall not constitute a “public offer” as defined by Legislative Decree 24 February 1998, no. 58 (“TUF”), and therefore drawing up a prospectus according to the models required by Community Regulation 809/2004/EC isn’t necessary. The Admission Document therefore shall not constitute a prospectus and publication needn’t be authorized by CONSOB as set forth in Community Directive no. 2003/71/EC or any other standard or regulation governing drawing up and publishing of financial prospectuses as set forth in article 94 and 113 of Legislative Decree 24 February 1998, no. 58 TUF, including the issuer regulations adopted by CONSOB with resolution no.11971 of 14 May 1999 and as amended and supplemented. The information on this section of the website is divulged in compliance with articles 17 and 26 of the AIM Issuer Regulations.

This section of the website, the Admission Document, and any other information on the pages below is accessible only to parties that: (i) reside in Italy and are neither domiciled nor in any event are currently in the United States of America, Australia, Japan, Canada, or in any other country where the divulgence of the Admission Document and/or such information requires the approval of the competent local authorities or breaks local laws or regulations (“Other Countries”); and (ii) are not “U.S. Persons”, according to the definition in Regulation S of the United States Securities Act of 1933 and as amended, nor are parties that act on their behalf or to their benefit without the existence of a designated registration or a specific exemption to registration required as set forth in the United States Securities Act and the current legislation.

The “U.S. Persons” in the sense indicated above are barred from any access to this section of the website, downloads, memorization and/or temporary or permanent saving of the Admission Document and any other information on this section of the website. The information on this section of the website may not be copied or sent. For no reason and under no circumstances shall it be allowed to send—either directly or through third parties—the Admission Document or any other information on this section of the website to parties in the conditions under points (i) and (ii) of the paragraph above, and specifically, in the United States, Australia, Japan, Canada, or the Other Countries.

The information on this website (or on any other website that this website has hyperlinks to) shall not constitute an offer, invitation to offer, or promotional activity for the Financial Instruments for any citizen or party residing in the United States, Australia, Japan, Canada, or the Other Countries. Moreover, the Financial Instruments of the Company are not—nor shall they be—registered as set forth in the United States Securities Act of 1983 and as amended, or with any other regulation authority of any state or other jurisdiction of the United States and shall not be offered or sold in the United States or to, or on behalf or benefit of, a “U.S. Person” as defined herein, in the absence of the above-said registration or express exemption from this obligation, or in Australia, Japan, Canada, or in Other Countries.

Regulation S of the United States Securities Act of 1933 and as amended defines a “U.S. Person“ as: (a)any natural person residing in the United States; (b) “partnerships” and “corporations” incorporated and organized according to the current legislation in the United States; (c) any property whose administrators or managers are a “U.S. Person“; (d) the trusts whose trustees are a “U.S. Person“; (e) any agency or branch of a party seated in the United States; (f) (“non-discretionary accounts“); (g) other similar accounts (except for property or trusts), managed or administered in trust on behalf of or to the benefit of a “U.S. Person“; (h) “partnerships” and “corporations” if (i) incorporated and organized according to the laws of any foreign jurisdiction; and (ii) incorporated by a “U.S. Person” with the main objective of investing in securities not registered as set forth in the United States Securities Act of 1933 and as amended unless they were incorporated or organized and held by accredited investors (according to the definition in Rule 501(a) of the United States Securities Act of 1933) that are not natural persons, property, or trusts.

To access this section of the website, the Admission Document, and any other information on the following pages, I state, under my full responsibility, to be a resident in Italy and neither to be domiciled nor to currently be in the United States, Australia, Japan, Canada, or the Other Countries, and not to be a “U.S. Person” as defined in Regulation S of the United States Securities Act del 1933 and as amended.

TERMINI E CONDIZIONI

Per poter accedere alla presente sezione del sito web è necessario leggere e accettare l’informativa di seguito riportata, che il lettore deve valutare attentamente prima di leggere, accedere o utilizzare in qualsiasi altra maniera le informazioni di seguito fornite. Accedendo alla presente sezione del sito web, si accetta di essere soggetti ai termini e alle condizioni di seguito riportati, che potrebbero essere modificati o aggiornati (e, per tale ragione, dovranno essere letti integralmente ogni volta che vi si accede).

Il prospetto informativo pubblicato nella presente sezione del sito web (“Prospetto Informativo”) è stato redatto ai sensi del regolamento di attuazione del D. Lgs. del 24 febbraio 1998, n. 58, concernente la disciplina degli emittenti, adottato dalla Consob con delibera n. 11971 del 14 maggio 1999, come successivamente modificato e integrato, e dell’articolo 2 del Regolamento Delegato (UE) n. 2019/980 della Commissione europea del 14 marzo 2019, recante le modalità di applicazione del Regolamento (UE) 2017/1129, come successivamente modificato e integrato ai fini dell’ammissione delle azioni ordinarie (le “Azioni”) di Alkemy S.p.A. (la “Società”) sul Mercato Telematico Azionario organizzato e gestito da Borsa Italiana S.p.A.

Non sussiste alcuna offerta di Azioni al pubblico e, pertanto, il Prospetto Informativo non costituisce un prospetto di offerta.

La presente sezione del sito web, il Prospetto Informativo e ogni altra informazione contenuta nelle seguenti pagine sono accessibili solo da soggetti che: (i) sono residenti in Italia e che non sono domiciliati né comunque si trovano attualmente negli Stati Uniti d’America, Australia, Giappone, Canada nonché in qualsiasi altro Paese in cui la diffusione del Prospetto Informativo e/o di tali informazioni richieda l’approvazione delle competenti Autorità locali o sia in violazione di norme o regolamenti locali (“Altri Paesi”); e (ii) non sono “U.S. Person”, secondo la definizione contenuta nella Regulation S dello United States Securities Act del 1933, come successivamente modificato, né sono soggetti che agiscono per loro conto o a loro beneficio senza l’esistenza di un’apposita registrazione o di una specifica esenzione alla registrazione prevista ai sensi dello United States Securities Act e della normativa vigente.

Alle “U.S. Person” nel senso sopra indicato è preclusa ogni possibilità di accesso alla presente sezione del sito web, di download, memorizzazione e/o salvataggio temporanei o duraturi del Prospetto Informativo e di ogni altra informazione contenuta nella presente sezione del sito web. Le informazioni contenute nella presente sezione del sito web non possono essere copiate o inoltrate. Per nessuna ragione e in nessuna circostanza è consentito far circolare, direttamente o tramite terzi, il Prospetto Informativo e ogni altra informazione contenuta nella presente sezione del sito web a soggetti che si trovino nelle condizioni di cui a punti (i) e (ii) del paragrafo che precede e, in particolare, negli Stati Uniti, in Australia, in Giappone, in Canada o negli Altri Paesi.

Le informazioni contenute nel presente sito web (o in qualsiasi altro sito col quale il presente sito web abbia collegamenti ipertestuali) non costituiscono offerta, invito ad offrire o attività promozionale in relazione alle Azioni nei confronti di alcun cittadino o soggetto residente negli Stati Uniti, in Australia, Giappone, Canada o negli Altri Paesi. Inoltre, le Azioni della Società non sono, né saranno, oggetto di registrazione ai sensi dello United States Securities Act del 1993, così come modificato, o presso alcuna autorità regolamentare di qualsiasi stato o altra giurisdizione degli Stati Uniti e non potranno essere offerti o venduti negli Stati Uniti o a, o per conto e beneficio di, una “U.S. Person”, come infra definito, in assenza della predetta registrazione o di espressa esenzione da tale adempimento, o in Australia, Giappone, Canada o in Altri Paesi.

La Regulation S dello United States Securities Act del 1933, come successivamente modificato, definisce quale “U.S. Person”: (a) ogni persona fisica residente negli Stati Uniti; (b) le “partnerships” e le “corporations” costituite e organizzate secondo la legislazione vigente negli Stati Uniti; (c) ogni proprietà i cui amministratori o gestori siano una “U.S. Person”; (d) i trust il cui trustee sia una “U.S. Person”; (e) ogni agenzia, filiale o succursale di un soggetto che abbia sede negli Stati Uniti; (f) i conti di carattere non discrezionale (“non-discretionary accounts”); (g) altri conti simili (eccetto proprietà o trust), gestiti o amministrati fiduciariamente per conto o a beneficio di una “U.S. Person”; (h) le “partnerships” e le “corporations” se (i) costituite ed organizzate secondo le leggi di qualsiasi giurisdizione straniera; e (ii) costituite da una “U.S. Person” con il principale obiettivo di investire in titoli non registrati ai sensi del United States Securities Act del 1933, come successivamente modificato, salvo che siano costituite o organizzate e possedute da investitori accreditati (secondo la definizione contenuta nel Rule 501(a) dello United States Securities Act del 1933) che non siano persone fisiche, proprietà o trust.

Per accedere alla presente sezione del sito web, al Prospetto Informativo e ad ogni altra informazione contenuta nelle seguenti pagine, dichiaro sotto la mia piena responsabilità di essere residente in Italia e di non essere domiciliato né di trovarmi attualmente negli Stati Uniti d’America, in Australia, Giappone, in Canada o negli Altri Paesi e di non essere una “U.S. Person” come definita nella Regulation S dello United States Securities Act del 1933, come successivamente modificato.
https://corporate.alkemy.com/en/documento/alkemy-s-p-prospetto-informativo_mta_star/

2025

2024

2023

2022

2021

2020

2019

2025

2021

2020

For the transmission and storage of the Regulated Information, the Company uses the transmission system eMarket SDIR and the storage device eMarket STORAGE which can be consulted on the website www.emarketstorage.com and are managed by Teleborsa S.r.l., with registered office in Rome, at 4, Piazza di Priscilla.

2025

2024

2023

2022

2021

2020

2019

2026

2024

2023

2022

2024

2024

2023

2022

2021

2020

2019

2018

Via San Gregorio, 34 - 20124 Milano

ir@alkemy.com

A New Corporate Identity for Alkemy and FSI’s Major Growth Project
11.10.2024 – Acquisto di azioni di Alkemy S.p.A. sul mercato
13.09.2024 – Pubblicazione della Relazione Finanziaria Semestrale al 30.06.2024
The Board of Directors approves the Half-Year Financial Report at June 30th, 2020 and, appoints Massimo Canturi, as General Manager of the Company. The Board of Directors approved the merger by incorporation into Alkemy S.p.A of the wholly owned subsidiary Biz-Up S.r.l.
30.03.2020 – Pubblication of the documentation related to Alkemy’s Shareholders’ meeting
25.03.2020 – FY2019 Results
2020.02.13_The Board of Directors of Alkemy S.p.A. co-opts Vittorio Massone as director to replace the resigned Matteo de Brabant and appoints him Deputy Chairman of the Company
2019.12.18_ Start of trading of the ordinary shares of Alkemy S.p.A. on MTA – STAR segment. 2019 projected operating results
2019.12.16_Borsa Italiana authorizes admission to listing of the ordinary shares of Alkemy S.p.A. on the STAR segment of Mercato Telematico Azionario First day of trading on MTA on17 December 2019
Alkemy-S.p.A Prospetto-Informativo_MTA_STAR
2019.12.12_Alkemy published the Prospectus relating to the admission to listing on the MTA, STAR segment, of the Company’s ordinary shares
2019.11.22_Report on the purchase of treasury shares
2019.11.15_Report on the purchase of treasury shares
2019.11.08_report on the purchase of treasury shares
2019.11.01_Report on the purchase of trasury shares
2019.10.25_Report on the purchase of treasury shares
2019.10.21_Alkemy @ London AIM Conference
2019.10.18_Report on the purchase of treasury shares
2019.10.11_Report on the purchase of treasury shares
2019.10.04_Report on the purchase of treasury shares
2019.10.03_Filed with Consob the request for approval of the Listing Prospectus concerning the admission to listing of Alkemy S.p.A. on the Mercato Telematico Azionario. Simultaneously submitted to Borsa Italiana the application for admission to listing of Alkemy S.p.A.’s ordinary shares on the MTA, STAR segment.
2019.09.30_Report on the purchase of treasury shares
2019.09.20_Report on the purchase of treasury shares
2019.08.27_The Board of Directors of Alkemy S.p.A. has approved the Interim Financial Report ended at June 30th, 2019.
2019.07.24_Alkemy S.p.A.: Communication of change in share capital
2019.07.16_Between Industrial Design and Internet of Things: Alkemy enters the capital of Design Group Italia with an initial 20% stake
2019.07.09_Alkemy SpA’s stake in BizUp S.r.l. rises to 100%
2019.06.25_The Shareholders’ Meeting of Alkemy S.p.A. approves the company’s transition to the MTA market
2019.06.10_Integration to the press release of May 27th 2019
Consolidated financial statement at 31.12.2018 (Only Italian)
2019.05.27_The Board of Directors of Alkemy SpA has resolved to submit to the Shareholders’ Meeting the Project for the admission of ordinary shares to listing on the MTA market
2019.05.27_AIM CONFERENCE – Alkemy Equity Story
2019.05.07_Alkemy S.p.A.’s 2018 Financial Statements have been approved at Ordinary Shareholders’ Meeting
2019.04.23_Report on the purchase of treasury shares
2019.04.04_Report on the purchase of treasury shares
2019.03.29_Report on the purchase of treasury shares
2019.03.28_The BoD approved the draft Consolidated Financial Statements for 2018
2019.03.22_Report on the purchase of treasury shares
2019.03.15_Report on the purchase of treasury shares
2019.03.08_Report on the purchase of treasury shares
2019.03.01 – Reporto on the purchase of treasury shares
2019.02.22 – Report on the purchase of treasury shares
2019.02.15_Report on the purchase of treasury shares
2019.02.08_Report on the purchase of treasury shares
2019.02.01_Report on the purchase of treasury shares
2019.01.30_Corporate Calendar 2019
2019.01.25_Report on the purchase of treasury shares
2019.01.18_Report on the purchase of treasury shares
2019.01.11_Report on the purchase of treasury shares
2018.12.21_Report on the purchase of treasury shares
2018.12.14_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.12.13_The Board of Directors has started the activities for the translisting process from the AIM Italia market to the MTA – STAR segment
2018.12.10_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.11.30_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.11.23_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.11.16_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.11.09_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.11.02_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.10.26_REPORT ON THE PURCHASE OF TREASURY SHARES
Alkemy S.p.A. – Prospetto Informativo MTA STAR
2018.10.22_Investor Presentation – AIM Italia Conference – London
2018.10.19_Report on the purchase of treasury shares
2018.10.12_Report on the purchase of treasury shares
2018.10.05_Report on the purchase of treasury shares
2018.09.27_Report on the purchase of treasury shares
Alkemy SpA_Half-Yearly Report 30 June 2018 (only in italian)
2018.09.28_Alkemy Board of Directors approved the Half-yearly report ended at June 30th 2018
2018.09.21_Report on the purchase of treasury shares
2018.09.14_Report on the purchase of treasury shares
2018.07.27_Report on the purchase of treasury shares
2018.07.26_Notification for relevant changes notified by significant shareholders.
2018.07.23_NOTIFICATION OF CHANGE IN SHARE CAPITAL AND SIGNIFICANT SHAREHOLDERS
2018.07.23_Supplement to press release issued on July 19, 2018
2018.07.19_Alkemy S.p.A. accelerates its external growth acquiring an initial 51% stake in the Spanish Group Ontwice Interactive Services SL
2018.07.13_Report on the purchase of treasury shares
2018.07.06_Report on the purchase of treasury shares
2018.06.29_Report on the purchase of treasury shares
2018.06.22_Report on the purchase oh treasury shares
2018.06.15_Report on the purchase of treasury shares
2018.06.08_Report on the purchase of treasury shares
2018.06.07_Kairos Partners exceeds the relevance threshold of the share capital of Alkemy S.p.A.
18.05.28 – AIM ITALIA CONFERENCE – ALKEMY EQUITY STORY
30.05.2018_Alkemy S.p.A. launches the second round of the treasury share Buyback Program
2018.05.03_Alkemy S.p.A.’s 2017 Financial Statements have been approved at Ordinary Shareholders’ Meeting
2018.04.26_Alkemy SEE buys 51% of Kreativa New Formula, Serbian independent marketing & advertising agency.
2018.04.20_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.04.13_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.04.06_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.03.30_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.03.28_2017 was a record year for Alkemy: net sales totalled €44.89 million, +28.9% compared to 2016, EBITDA was €5.06 million, +26% compared to 2016
2018.03.23_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.03.16_REPORT ON THE PURCHASE OF TREASURY SHARE
2018.03.15_Four months after listing on the AIM market, Alkemy S.p.A. buys 70% of Nunatac, leading company in Big Data & Analytics
2018.03.09_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.03.02_REPORT ON THE PURCHASE OF TREASURY SHARES
2018.02.19_Alkemy S.p.A.: launch of the treasury share Buyback Program
2018.02.09_Joint Venture between the Serbian subsidiary of Alkemy S.p.A. and Nelt Group
2018.01.15_Alkemy S.p.A. Financial Calendar 2018
2017.12.20_Alkemy S.p.A.: Full exercise of the Greenshoe option
2017.12.05_ALKEMY S.P.A debuts on the AIM Italia market of Borsa Italiana
2017.12.01_ALKEMY S.P.A. ADMISSION TO TRADING ON AIM ITALIA
2017.11.27_Alkemy S.p.A. submits application for admission of shares on the AIM Italia
2017.11.16_Alkemy S.p.A. Shareholders’ Meeting approves the listing on the AIM Italia market of Borsa Italiana

    14.07.2025 – PR disseminated on behalf of Retex S.p.A. – Settlement of the joint procedure and delisting of Alkemy shares (Italian Only)

    08.07.2025 – PR disseminated on behalf of Retex S.p.A. – Purchase by Retex of n. 270,724 Alkemy Shares by Duccio Vitali, in execution of the agreement of March 31, 2025(Italian Only)

    07.07.2025 – PR disseminated on behalf of Retex S.p.A. – Final results of the totalitarian tender offer (Italian Only)

    04.07.2025 – PR disseminated on behalf of Retex S.p.A. – preliminary results of the Totalitarian tender offer (Italian Only)

    01.07.2025 – PR disseminated on behalf and in the name of Retex S.p.A. – Società Benefit: signing of an amendment to the agreement between Duccio Vitali and Retex (Italian Only)

    01.07.2025 – PR disseminated on behalf and in the name of Retex S.p.A. – Società Benefit: passing of the 95% threshold of Alkemy Share Capital (Italian Only)

    30.06.2025 – PR disseminated on behalf and in the name of Retex S.p.A. – Società Benefit: last week to tender Alkemy shares (Italian Only)

    05.06.2025 – PR disseminated on behalf and in the name of Retex S.p.A. – Società Benefit: notice of pubblication of the information document related to the procedure for fulfilling the obligation to purchase pursuant to art. 108 and 109 of the Consolidated Law on Finance (Italian Only)

    05.06.2025 – Information Document related to the Mandaory Purchase Procedure regarding Alkemy S.p.A. shares (Italian Only)

    05.06.2025 – Sell Request Form (Italian Only)

    04.06.2025 – Press Release on Behalf of Retex S.p.A. – Società Benefit (Italian Only)

    22.04.2025 – Procedure for the fulfillment of the obligation to purchase pursuant to Artt. 108, par. 2, and 109 of Consolidated Finance Act: amendment and integration to the agreement between Retex and Duccio Vitali, subscription between Retex and Paolo Cederle of a sale and purchase agreement

    11.04.2025 – Press release issued in the name and on behalf of Retex S.p.A. – Filing of the information document and request for the determination of the sell-out consideration (Italian Only)

    08.11.2024 – Announcement of a share purchase on the market (Italian Version)

    15.10.2024 – Announcement of a share purchase on the market (Italian Version)

    11.10.2024 – Final results following the reopening period of the offer (Italian Version)

    11.10.2024 – Announcement of a share purchase on the market (Italian Version)

    10.10.2024 – Conclusion of the reopening period and provisional results of the offer (Italian Version)

    10.10.2024 – Announcement of a share purchase on the market (Italian Version)

    09.10.2024 – Determination of the number of shares to be tendered by Duccio Vitali on the last day of the reopening period (Italian Version)

    09.10.2024 – Announcement of a share purchase on the market (Italian Version)

    07.10.2024 – Announcement of a share purchase on the market (Italian Version)

    04.10.2024 – Purchase announcement outside of the Public Tender Offer (Italian Version)

    27.09.2024 – Final results of the tender and confirmation of the reopening of the acceptance period (Italian Version)

    26.09.2024 – Closing of the acceptance period and provisional results of the tender (Italian Version)

    26.09.2024 – The number of Alkemy shares that Duccio Vitali will confere to the Offer tomorrow, September 26th, 2024, has been determined at 110,000 (Italian Version)

    24.09.2024 – Scheda di adesione (Italian Version)

    24.09.2024 – Purchase of Alkemy S.p.A. shares on the market and aggregate participation of Retex and Duccio Vitali over 50%+1 of the voting rights (Italian version)

    24.09.2024 – Amendment and integration to the agreement between Retex and Duccio Vitali, waiver of the threshold condition and extension of the offer acceptance period (Italian version)

    23.09.2024 – Purchase of Alkemy S.p.A. shares on the market, waiver of the increased voting rights by Twinfin S.r.l. and extension of the deadline for the execution of the reinvestment of Twinfin S.r.l. (Italian version)

    19.09.2024 – Scheda di adesione (Italian Version)

    19.09.2024 – Extension of the acceptance period (Italian Version)

    18.09.2024 – Acceptance and Reinvestment Agreement with FMCC S.r.l. (Italian Version)

    16.09.2024 – Change of the threshold conditions (Italian Version)

    09.09.2024 – Integration to the Issuer’s Statement ex. art. 103 TUF issued on August 8th 2024

    09.09.2024 – The BoD approves the integration to the Issuer’s Statement ex. art. 103 TUF published on August 8th 2024

    04.09.2024 – Communication on behalf of certain shareholders – Commitment not to accept to the voluntary total takeover bid launched by Retex SpA – Benefit Company

    19.08.2024 – Start of the acceptance period

    08.08.2024 – Issuer’s statement pursuant to article 103 TUF

    08.08.2024 – The BoD approves the Issuer’s statement ex. article 103 TUF

    07.08.2024 – Accordo di adesione e reinvestimento Twinfin S.r.l. (Italian only)

    25.07.2024 – Bilancio consolidato di Retex S.p.A. per l’esercizio chiuso al 31.12.2023 (Italian only)

    25.07.2024 – Statuto sociale di Retex S.p.A. (Italian only)

    25.07.2024 – Scheda di adesione (Italian only)

    25.07.2024 – Documento di offerta (Italian only)

    25.07.2024 – Publication of the offer document

    15.07.2024 – Communication puruant to Art. 38 paragraph 1 and 36 RE (Riavvio termini istruttori – Reopening review period)

    12.07.2024 – Communication pursuant to Art. 36 RE (Autorizzazione AGCM – Antitrust Clearance)

    05.07.2024 – Notice pursuant to Article 41, Paragraph 2, Letter c) of Issuers’ Regulation

    28.06.2024 – Comunicato ai sensi dell’art. 38, comma 1 RE (Italian only)

    21.06.2024 – Appointment of the Financial Advisor in relation to the voluntary totalitarian tender offer launched by Retex S.p.A. – Società benefit on the Alkemy S.p.A. shares

    14.06.2024 – Comunicato ex-art. 36 RE (courtesy translation)

    13.06.2024 – Notice pursuant to Article 41, Paragraph 2, Letter c) of Issuers’ Regulation

    03.06.2024 – Retex S.p.A. announcement

    Alkemy Share
    No. of shares issued on 05/12/20171.700.000
    Price11,75 €
    Total number of shares on 05/12/20175.403.330
    Market capitalization on 05/12/2017€ 63.489.127,5

    On July 14th, 2025 the Alkemy S.p.A. share capital subscribed and paid is equal to € 606,317.72 and consists of n. 5,793,294 shares.

    CORPORATE EVENT CALENDAR
    15 MAY 2025

    Board of Directors’ Meeting

    Approval of the Quarterly Financial Report as of March 31st, 2025
    30 APRIL 2025

    Ordinary Shareholders’ Meeting

    Approval of the Separate and Consolidated Financial Statements as of December 31st, 2024
    27 MARCH 2025

    Board of Directors’ Meeting

    Approval of the draft Financial Statements and Consolidated Financial Statements as of December 31st, 2024
    26 FEBRUARY 2025

    Board of Directors’ Meeting

    Disclosure of certain economic results as at December 31st, 2024 (consolidated revenues and Adjusted EBITDA), not subject to auditing

    14 NOVEMBER 2023

    Board of Directors’ Meeting

    Approval of the Interim Financial Report as of September 30th, 2023
    14 SEPTEMBER 2023

    Board of Directors’ Meeting

    Approval of the Half Yearly Report as of June 30th, 2023
    4 AUGUST 2023

    Board of Directors’ Meeting

    Disclosure of certain operating economic results as of June 30th, 2023
    15 MAY 2023

    Board of Directors’ Meeting

    Approval of the Quarterly Financial Report as of March 31st, 2023.
    27 APRIL 2023

    Ordinary Shareholders’ Meeting

    Approval of the Separate and Consolidated Financial Statements as of December 31st, 2022
    27 MARCH 2023

    Board of Directors’ Meeting

    Approval of the Draft Financial Statements as of December 31st, 2022
    23 FEBRUARY 2023

    Board of Directors’ Meeting

    Disclosure of certain operating economic results as of December 31st, 2022.
    14 NOVEMBER 2024

    Board of Directors’ Meeting

    Approval of the Interim Financial Report as of September 30th, 2024.
    13 SEPTEMBER 2024

    Board of Directors’ Meeting

    Approval of the Half-Year Financial Report as of June 30th, 2024.
    8 AUGUST 2024

    Board of Directors’ Meeting

    Disclosure of certain operating economic results as at June 30th, 2024 (consolidated revenues and Adjusted EBITDA), not subject to auditing.
    15 MAY 2024

    Board of Directors’ Meeting

    Approval of the Quarterly Financial Report as of March 31st, 2024.
    29 APRIL 2024

    Ordinary Shareholders’ Meeting

    Approval of the Separate and Consolidated Financial Statements as of December 31st, 2023.
    28 MARCH 2024

    Board of Directors’ Meeting

    Approval of the draft Financial Statements and Consolidated Financial Statements as of December 31st, 2023.
    23 FEBRUARY 2024

    Board of Directors’ Meeting

    Disclosure of certain operating economic results as at December 31st, 2023 (consolidated revenues and Adjusted EBITDA), not subject to auditing.
    14 NOVEMBER 2022

    Board of Directors meeting

    Approval of the financial report as of 30 September 2022
    13 SEPTEMBER 2022

    Board of Directors meeting

    Approval of the halfyearly financial report as of June 30, 2022
    13 MAY 2022

    Board of Directors meeting

    Approval of the quarterly financial report as of March 31, 2022
    26 APRIL 2022

    Ordinary Shareholders’ Meeting

    Approval of the Separate and Consolidated Financial Statements as of December 31, 2021
    22 MARCH 2022

    Board of Directors meeting

    Approval of the draft Financial Statements and Consolidated Financial Statements as of 31 December 2021
    22 FEBRUARY 2022

    Board of Directors meeting

    Disclosure of certain operating economic results as at December 31, 2021 (consolidated revenues and Adjusted EBITDA not subject to auditing)
    12 NOVEMBER 2021

    Board of Directors meeting

    Approval of the financial report as of 30 September 2021
    13 SEPTEMBER 2021

    Board of Directors meeting.

    Approval of the halfyearly financial report as of June 30, 2021
    14 MAY 2021

    Board of Directors meeting

    Approval of the quarterly financial report as of March 31, 2021
    26 APRIL 2021

    Ordinary Shareholders’ Meeting

    Approval of the Separate and Consolidated Financial Statements as of December 31, 2020
    22 MARCH 2021

    Board of Directors meeting

    Approval of the draft Financial Statements and Consolidated Financial Statements as of 31 December 2020
    12 FEBRUARY 2021

    Board of Directors meeting

    Disclosure of certain operating economic results as at December 31, 2020 (consolidated revenues and EBITDA not subject to auditing)
    13 NOVEMBER 2020

    Board of Directors meeting

    Approval of the financial report as of 30 September 2020.
    11 SEPTEMBER 2020

    Meeting of the Board of Director

    Approval of the halfyearly financial report as of June 30, 2020
    14 MAY 2020

    Board of Directors meeting.

    Approval of the quarterly financial report as of March 31, 2020
    24 APRIL 2020

    Ordinary Shareholders’ Meeting

    Approval of the Separate and Consolidated Financial Statements as of December 31, 2019
    24 MARCH 2020

    Board of Directors meeting

    Approval of the draft Financial Statements and Consolidated Financial Statements as of 31 December 2019
    28 MARCH 2019

    Board of Directors meeting

    Approve the draft of financial statements for the year and the consolidated financial statements at 31 December 2018.
    30 APRIL 2019

    Shareholders’ Meeting

    Approve the Financial Statements at 31 December 2018.
    27 AUGUST 2019

    Board of Directors meeting

    Approve the half-yearly financial report.
    28 MARCH 2018

    Board of Directors meeting

    Approve the draft of financial statements for the year and the consolidated financial statements at 31 December 2017.
    30 APRIL 2018

    Shareholders’ Meeting

    Approve the Financial Statements at 31 December 2017.
    28 SEPTEMBER 2018

    Board of Directors meeting

    Approve the half-yearly financial report.
    Alkemy

    ALKEMY SPA, SOCIETÀ SOGGETTA ALL’ATTIVITÀ DI DIREZIONE E COORDINAMENTO DI RETEX S.P.A. – SOCIETÀ BENEFIT | P.IVA 05619950966 REG. DELLE IMPRESE DI MILANO - CAP. SOC. 606.317,72 EURO I.V.

    PRIVACY POLICY
    Group Created with Sketch.

    PRIVACY NOTICE

    PRIVACY NOTICE PURSUANT TO ARTICLES 13 AND 14 OF REGULATION (EU) 2016/679 AND LEGISLATIVE DECREE NO. 196/2003, AS AMENDED BY LEGISLATIVE DECREE NO. 101/2018

    The Data Controllers (the “Controllers”) and, for processing carried out for Marketing and Communication purposes, the Joint Controllers (the “Joint Controllers”), as defined below, pursuant to Article 13 of Regulation (EU) 2016/679 (the “Regulation”), hereby inform you of the purposes for which your personal data are collected and processed, in accordance with the principles of lawfulness, fairness and transparency, ensuring confidentiality and compliance with the applicable legislation.

    1. Data Controllers / Joint Controllers

    ALKEMY S.p.A. (“Data Controller”)
    Registered office: Via San Gregorio, 34 - 20124 Milano (MI)
    e-mail: privacy@alkemy.com

    ALKEMY PLAY S.r.l. (“Data Controller”)
    Registered office: Via San Gregorio, 34 - 20124 Milano (MI)
    e-mail: privacy@alkemy.com

    COSMIC S.r.l. (“Data Controller”)
    Registered office: Via Monte Rosa, 91 - 20149 Milano (MI)
    e-mail: gdpr@retex.com

    D.COM S.r.l. (“Data Controller”)
    Registered office: Via San Gregorio, 34 - 20124 Milano (MI)
    e-mail: gdpr@retex.com

    DIGITAL RETEX S.r.l. (“Data Controller”)
    Registered office: Via San Gregorio, 34 - 20124 Milano (MI)
    e-mail: gdpr@retex.com

    RETEX S.p.A. (“Data Controller”)
    Registered office: Via San Gregorio, 34 - 20124 Milano (MI)
    e-mail: gdpr@retex.com

    WTL S.r.l. (“Data Controller”)
    Registered office: Via San Gregorio, 34 - 20124 Milano (MI)
    e-mail: gdpr@retex.com

    XCC S.r.l. (“Data Controller”)
    Registered office: Via del Commercio, 36 - 00154 Roma (RM)
    e-mail: privacy@alkemy.com

    hereinafter collectively referred to as the “Companies”, the “Controllers” or, for Marketing and Communication purposes, the “Joint Controllers”.

    For purposes related to the performance of contractual obligations, compliance with legal obligations and the establishment, exercise or defence of legal claims, as further detailed in Section 4 below, each Company acts as an independent Data Controller pursuant to the Regulation, independently determining the purposes and means of processing. With regard to Marketing and Communication activities, as further detailed in Section 4, the Companies act as Joint Controllers, jointly determining, each within the scope of its responsibilities, the purposes and means of processing. In their capacity as Joint Controllers, the Companies have entered into a joint controllership agreement pursuant to Article 26 of the Regulation, an extract of which is available upon request by data subjects.

    2. Data Protection Officer (DPO)

    The Controllers/Joint Controllers have appointed a Group Data Protection Officer (DPO), who may be contacted for any matter relating to the processing of personal data, including requests regarding the extract of the joint controllership agreement pursuant to Article 26 of the Regulation, and for the exercise of data subjects’ rights. Contact details of the DPO: privacy@alkemy.com.

    3. Categories of personal data processed

    Processing may concern common personal data, identification and contact data, collected directly or through third parties, including – by way of example and not limitation – identification details (name, surname, address, telephone number, business email address, company/studio details, industry, job title, role and function, and similar information), also relating to representatives, employees, collaborators or persons otherwise connected to your professional activity, as well as fiscal and administrative data necessary for contract management (tax code, VAT number, IBAN and bank/postal details). No special categories of personal data are processed.

    4. Purposes and legal basis of processing

    4.1 Contractual relationship management. Each Data Controller processes personal data of its clients/users to provide the requested services and for purposes strictly connected with and instrumental to the management and performance of pre-contractual and/or contractual relationships, as well as for compliance with legal and regulatory obligations and instructions issued by competent authorities. Processing is necessary to carry out activities related to the purchase of services and/or products, such as order management, service provision and/or production and/or shipment of purchased products, invoicing and payment management, handling of complaints and support requests, provision of customer support, sending of informational communications related to the service and/or contract, and compliance with contractual obligations.
    Legal basis: Article 6(1)(b) and (c) of the Regulation.

    4.2 Establishment, exercise or defence of legal claims. Personal data are processed in order to establish, exercise or defend the rights of the Data Controller and/or to defend against claims, in judicial or out-of-court proceedings.
    Legal basis: Article 6(1)(f) of the Regulation.

    4.3 Marketing and Communication. The Joint Controllers jointly process data collected in the course of their activities for Strategic Marketing, Brand and Corporate Communication purposes, including:

    Legal basis: Article 6(1)(a) of the Regulation (consent of the data subject).

    iii) The Joint Controllers may send emails relating to promotions and offers of services/products similar or related to those already purchased by the data subject, unless the data subject has objected to such processing at the outset or subsequently.
    Legal basis: Article 130(4) of Legislative Decree No. 196/2003. The data subject has the right to object at any time to processing for this purpose.

    5. Mandatory or optional nature of data provision

    5.1 Provision of personal data is mandatory for the purposes referred to in Sections 4.1 and 4.2.

    5.2 Provision of data for the purposes referred to in Section 4.3 is optional and subject to the data subject’s consent. Any refusal will not affect the performance of the requested services.

    5.3 With reference to the purposes under Section 4.3, the Joint Controllers have jointly defined the processing methods and procedures for responding to data subjects’ requests pursuant to Articles 15–22 of the Regulation. The single point of contact for the exercise of rights is the Group DPO, whose contact details are provided in Section 2. An extract of the joint controllership agreement is available upon request.

    6. Processing methods and data retention

    6.1 Personal data are processed by authorised and trained personnel, lawfully and fairly, with or without electronic or automated means, and include all operations necessary for the processing, including recording and storage, with appropriate security measures to ensure confidentiality and protection against unauthorised access, disclosure, misuse or loss. No automated decision-making processes pursuant to Article 22 of the Regulation are carried out.

    6.2 For the purposes under Sections 4.1 and 4.2, personal data are retained for the time strictly necessary to achieve the purposes for which they were collected, to comply with legal obligations related to administrative, accounting, tax and social security matters (10 years), and for the duration of any disputes, without prejudice to further legal obligations.

    6.3 For Marketing and Communication purposes: a) purposes under Section 4.3(i): up to 24 months from the last interaction; b) purposes under Section 4.3(ii): up to 12 months from the last interaction; c) purposes under Section 4.3(iii): up to 24 months from termination of the relationship.

    7. Data disclosure

    7.1 Personal data may be shared among the Joint Controllers and with authorised employees, staff and collaborators for the purposes set out in Section 4.

    7.2 Personal data may also be disclosed to third parties to comply with legal obligations or to entities such as, by way of example, external consultants, banks and financial institutions, professionals, IT maintenance providers, service providers for information systems, websites, web applications and telecommunications networks, as well as any other third parties involved in the performance of contractual obligations. Such parties shall act as independent Data Controllers or Data Processors, in accordance with applicable instructions.

    7.3 The updated list of Data Processors is maintained by each Company and is available upon request.

    8. Data transfers

    8.1 Personal data are not processed or transferred outside the European Union. Where transfers to third countries become necessary, including for data storage purposes, such transfers shall take place in compliance with the Regulation, applicable law and appropriate safeguards, including Standard Contractual Clauses approved by the European Commission or equivalent measures.

    9. Rights of the data subject

    Pursuant to Articles 15–22 of the Regulation, you have the right to:

    These rights may be exercised by contacting the Group DPO at the details provided in Section 2.

    10. Amendments

    The Controllers/Joint Controllers reserve the right to amend or update this Privacy Notice, in whole or in part, also as a result of changes in applicable legislation. Any amendments will be communicated in a timely manner.